Founded in 1963, Garvan’s researchers have made significant advances in genome, epigenome, protein and cell analysis technology. They’ve revealed causes and treatments for diseases including diabetes, osteoporosis, cancer, immune deficiency and autoimmunity.
Garvan is affiliated with St Vincent’s Hospital, Sydney and UNSW Sydney.
Vision and mission
The Garvan Institute of Medical Research sees a future where we’re able to stop disease before it starts.
Its mission is to harness all the information encoded in our genome to better diagnose, treat, predict and prevent disease.
How the Garvan Institute of Medical Research can help
The institute is focused on addressing the unmet needs of those living with disease – where better understanding, new treatments and more effective diagnosis can have the biggest impact. It runs a number of clinical trials and cutting-edge research programs for a range of diseases.
Programs and apps
- DreamLab App harnesses the processing power of smartphones to crunch cancer problems to help complete research faster
- Genomic Cancer Medicine Program uses genomics to improve the understanding, early detection, prevention and management of cancer
- The Australian Parkinson's Mission discovers how to slow, stop and cure the disease
- CIRCA program improves the lives of patients with rare immune conditions
- Zero Childhood Cancer Program guides personalised medicine treatment approaches